Literature DB >> 27672191

Fluorescent Reporter DS6A Mycobacteriophages Reveal Unique Variations in Infectibility and Phage Production in Mycobacteria.

Oren Mayer1, Paras Jain1, Torin R Weisbrod1, Daniel Biro2, Libby Ho1, Deborah Jacobs-Sera3, Graham F Hatfull3, William R Jacobs4,5,6.   

Abstract

Mycobacteriophage DS6A is unique among the more than 8,000 isolated mycobacteriophages due to its ability to form plaques exclusively on mycobacteria belonging to the Mycobacterium tuberculosis complex (MTBC). Speculation surrounding this specificity has led to unsupported assertions in published studies and patents that nontuberculous mycobacteria (NTM) are wholly resistant to DS6A infection. In this study, we identified two independent nonessential regions in the DS6A genome and replaced them with an mVenus-expressing plasmid to generate fluorescent reporter phages Φ2GFP12 and Φ2GFP13. We show that even though DS6A is able to form plaques only on MTBC bacteria, infection of various NTM results in mVenus expression in transduced cells. The efficiency of DS6A in delivering DNA varied between NTM species. Additionally, we saw a striking difference in the efficiency of DNA delivery between the closely related members of the Mycobacterium abscessus complex, M. abscessus and Mycobacterium massiliense We also demonstrated that TM4 and DS6A, two phages that do not form plaques on M. massiliense, differ in their ability to deliver DNA, suggesting that there is a phage-specific restriction between mycobacterial species. Phylogenetic analysis reveals that the DS6A genome has a characteristically mosaic structure but provided few insights into the basis for the specificity for MTBC hosts. This study demonstrates that the inability of the MTBC-specific phage DS6A to form plaques on NTM is more complex than previously thought. Moreover, the DS6A-derived fluorophages provide important new tools for the study of mycobacterial biology. IMPORTANCE: The coevolution of bacteria and their infecting phages involves a constant arms race for bacteria to prevent phage infection and phage to overcome these preventions. Although a diverse array of phage defense systems is well characterized in bacteria, very few phage restriction systems are known in mycobacteria. The DS6A mycobacteriophage is unique in the mycobacterial world in that it forms plaques only on members of the Mycobacterium tuberculosis complex. However, the novel DS6A reporter phages developed in this work demonstrate that DS6A can infect nontuberculous mycobacteria at various efficiencies. By comparing the abilities of DS6A and another phage, TM4, to infect and form plaques on various mycobacterial species, we can begin to discern new phage restriction systems employed within the genus.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27672191      PMCID: PMC5105902          DOI: 10.1128/JB.00592-16

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  46 in total

Review 1.  Role of CRISPR/cas system in the development of bacteriophage resistance.

Authors:  Agnieszka Szczepankowska
Journal:  Adv Virus Res       Date:  2012       Impact factor: 9.937

2.  Mycobacteriophage-repressor-mediated immunity as a selectable genetic marker: Adephagia and BPs repressor selection.

Authors:  Zaritza O Petrova; Gregory W Broussard; Graham F Hatfull
Journal:  Microbiology       Date:  2015-06-11       Impact factor: 2.777

3.  Phamerator: a bioinformatic tool for comparative bacteriophage genomics.

Authors:  Steven G Cresawn; Matt Bogel; Nathan Day; Deborah Jacobs-Sera; Roger W Hendrix; Graham F Hatfull
Journal:  BMC Bioinformatics       Date:  2011-10-12       Impact factor: 3.169

Review 4.  Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration.

Authors:  Jacqueline M Achkar; Stephen D Lawn; Mahomed-Yunus S Moosa; Colleen A Wright; Victoria O Kasprowicz
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

5.  A new bioinformatics analysis tools framework at EMBL-EBI.

Authors:  Mickael Goujon; Hamish McWilliam; Weizhong Li; Franck Valentin; Silvano Squizzato; Juri Paern; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2010-05-03       Impact factor: 16.971

6.  Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21 T, My-327.

Authors:  L Sula; J Sulová; M Stolcpartová
Journal:  Czech Med       Date:  1981

7.  Noncanonical SMC protein in Mycobacterium smegmatis restricts maintenance of Mycobacterium fortuitum plasmids.

Authors:  Michael W Panas; Paras Jain; Hui Yang; Shimontini Mitra; Debasis Biswas; Alice Rebecca Wattam; Norman L Letvin; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

8.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.

Authors:  Fabian Sievers; Andreas Wilm; David Dineen; Toby J Gibson; Kevin Karplus; Weizhong Li; Rodrigo Lopez; Hamish McWilliam; Michael Remmert; Johannes Söding; Julie D Thompson; Desmond G Higgins
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

Review 9.  Mycobacteriophages: windows into tuberculosis.

Authors:  Graham F Hatfull
Journal:  PLoS Pathog       Date:  2014-03-20       Impact factor: 6.823

10.  Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity.

Authors:  Welkin H Pope; Charles A Bowman; Daniel A Russell; Deborah Jacobs-Sera; David J Asai; Steven G Cresawn; William R Jacobs; Roger W Hendrix; Jeffrey G Lawrence; Graham F Hatfull
Journal:  Elife       Date:  2015-04-28       Impact factor: 8.140

View more
  13 in total

1.  Utilization of CRISPR Interference To Validate MmpL3 as a Drug Target in Mycobacterium tuberculosis.

Authors:  Matthew B McNeil; Gregory M Cook
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  Resolving the structure of phage-bacteria interactions in the context of natural diversity.

Authors:  Kathryn M Kauffman; William K Chang; Julia M Brown; Fatima A Hussain; Joy Yang; Martin F Polz; Libusha Kelly
Journal:  Nat Commun       Date:  2022-01-18       Impact factor: 14.919

3.  Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains.

Authors:  Carlos A Guerrero-Bustamante; Rebekah M Dedrick; Rebecca A Garlena; Daniel A Russell; Graham F Hatfull
Journal:  mBio       Date:  2021-05-20       Impact factor: 7.867

4.  Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.

Authors:  Catherine Vilchèze; Jacqueline Copeland; Tracy L Keiser; Torin Weisbrod; Jacqueline Washington; Paras Jain; Adel Malek; Brian Weinrick; William R Jacobs
Journal:  mBio       Date:  2018-05-29       Impact factor: 7.867

5.  Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells.

Authors:  Christian Møller-Olsen; Siu Fung Stanley Ho; Ranti Dev Shukla; Tamas Feher; Antonia P Sagona
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

6.  Fluoromycobacteriophages Can Detect Viable Mycobacterium tuberculosis and Determine Phenotypic Rifampicin Resistance in 3-5 Days From Sputum Collection.

Authors:  Liliana Rondón; Estefanía Urdániz; Cecilia Latini; Florencia Payaslian; Mario Matteo; Ezequiel J Sosa; Darío F Do Porto; Adrian G Turjanski; Sergio Nemirovsky; Graham F Hatfull; Susana Poggi; Mariana Piuri
Journal:  Front Microbiol       Date:  2018-07-05       Impact factor: 5.640

7.  Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review.

Authors:  Taher Azimi; Mehrdad Mosadegh; Mohammad Javad Nasiri; Sahar Sabour; Samira Karimaei; Ahmad Nasser
Journal:  Infect Drug Resist       Date:  2019-09-17       Impact factor: 4.003

Review 8.  Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis.

Authors:  Anna Allué-Guardia; Rajagopalan Saranathan; John Chan; Jordi B Torrelles
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

Review 9.  Reporter Phage-Based Detection of Bacterial Pathogens: Design Guidelines and Recent Developments.

Authors:  Susanne Meile; Samuel Kilcher; Martin J Loessner; Matthew Dunne
Journal:  Viruses       Date:  2020-08-26       Impact factor: 5.048

10.  Arrayed CRISPRi and quantitative imaging describe the morphotypic landscape of essential mycobacterial genes.

Authors:  Timothy J de Wet; Kristy R Winkler; Musa Mhlanga; Valerie Mizrahi; Digby F Warner
Journal:  Elife       Date:  2020-11-06       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.